These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 20057389)

  • 21. Biomarkers for breast cancer.
    Beenken SW; Bland KI
    Minerva Chir; 2002 Aug; 57(4):437-48. PubMed ID: 12145573
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Tumor markers in the diagnosis and prognosis of breast cancer].
    Seliuzhitskiĭ IV; Skvortsov SV; Lytsar BN; Khomenko LP
    Klin Med (Mosk); 1993; 71(2):25-7. PubMed ID: 8046917
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circulating tumor markers in breast cancer.
    Tondini C; Hayes DF; Kufe DW
    Hematol Oncol Clin North Am; 1989 Dec; 3(4):653-74. PubMed ID: 2691493
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum biomarkers for detection of breast cancers: A prospective study.
    Mathelin C; Cromer A; Wendling C; Tomasetto C; Rio MC
    Breast Cancer Res Treat; 2006 Mar; 96(1):83-90. PubMed ID: 16322896
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systemic microRNAs: novel biomarkers for colorectal and other cancers?
    Heneghan HM; Miller N; Kerin MJ
    Gut; 2010 Jul; 59(7):1002-4; author reply 1004. PubMed ID: 20581247
    [No Abstract]   [Full Text] [Related]  

  • 26. [Tumor markers in gynecological and breast cancer].
    Jobo T; Sato R; Kuramoto H
    Rinsho Byori; 2003 Dec; 51(12):1188-94. PubMed ID: 14743742
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Mucin markers in metastatic breast cancer].
    Bieglmayer C; Breitenecker G; Szepesi T
    Gynakol Rundsch; 1990; 30 Suppl 1():142-4. PubMed ID: 2079249
    [No Abstract]   [Full Text] [Related]  

  • 28. [Diagnostic value of combined detection of TPS, CA153 and CEA in breast cancer].
    Zheng H; Luo RC
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Oct; 25(10):1293-4, 1298. PubMed ID: 16234113
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Tumor markers MCA and CA-125 in the diagnosis and monitoring of breast cancer].
    Shakhtarin VV; Izotova IA; Parshkov EM; Chekin SIu; Simakova GM
    Vopr Onkol; 1992; 38(4):433-9. PubMed ID: 1300737
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined measurement of serum sialyl Lewis X with serum CA15-3 in breast cancer patients.
    Kurebayashi J; Nomura T; Hirono M; Okubo S; Udagawa K; Shiiki S; Ikeda M; Nakashima K; Tanaka K; Sonoo H
    Jpn J Clin Oncol; 2006 Mar; 36(3):150-3. PubMed ID: 16520359
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [C-erb B-2 protein in the sera of breast cancer patients].
    Narita T; Funahashi H; Satoh Y; Takagi H
    Gan To Kagaku Ryoho; 1992 Jun; 19(6):909-11. PubMed ID: 1351384
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical evaluation of new serum tumor markers CA M26 and CA M29 in patients with primary breast cancer.
    Eskelinen M; Tikanoja S; Brown J
    Anticancer Res; 1990; 10(4):959-62. PubMed ID: 2382995
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liquid chromatography mass spectrometry for quantifying plasma lysophospholipids: potential biomarkers for cancer diagnosis.
    Murph M; Tanaka T; Pang J; Felix E; Liu S; Trost R; Godwin AK; Newman R; Mills G
    Methods Enzymol; 2007; 433():1-25. PubMed ID: 17954226
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autoantibody to tumor antigen, alpha 2-HS glycoprotein: a novel biomarker of breast cancer screening and diagnosis.
    Yi JK; Chang JW; Han W; Lee JW; Ko E; Kim DH; Bae JY; Yu J; Lee C; Yu MH; Noh DY
    Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1357-64. PubMed ID: 19423516
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor associated glycoprotein (TAG) 12: a new tumor marker in breast cancer.
    Heinze T; Lichtenegger W
    Anticancer Res; 2000; 20(6D):5049-52. PubMed ID: 11326666
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Integration of new and future biomarkers in the treatment of breast cancer].
    Würtz SØ; Henriksen KL; Lykkesfeldt A; Celis J; Brünner NA
    Ugeskr Laeger; 2007 Sep; 169(36):2999-3003. PubMed ID: 17953881
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Diagnostic contribution of serum levels of tumor markers in adenocarcinoma of the breast].
    Cioffi M; Fratta M; De Lucia D; Bresciani F
    J Nucl Med Allied Sci; 1990; 34(4 Suppl):33-4. PubMed ID: 2092145
    [No Abstract]   [Full Text] [Related]  

  • 38. CAM 26 and CAM 29: methodological evaluations and first clinical employment in breast cancer.
    Priolo G; Pecchio F; Rapellino M; Aimo G; Spertino F; Pepe C
    J Nucl Med Allied Sci; 1990; 34(4 Suppl):21-3. PubMed ID: 2092121
    [No Abstract]   [Full Text] [Related]  

  • 39. A prospective study of tissue polypeptide specific antigen (TPS) in breast cancer diagnosis.
    Eskelinen M; Hippeläinen M; Salmela E; Paajanen H; Alhava E; Syrjänen K
    Anticancer Res; 1992; 12(6B):2033-6. PubMed ID: 1295446
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased levels of tumor markers in the follow-up of 400 patients with breast cancer without recurrence or metastasis: interpretation of false-positive results.
    Zervoudis S; Peitsidis P; Iatrakis G; Panourgias E; Koureas A; Navrozoglou I; Dubois JB
    J BUON; 2007; 12(4):487-92. PubMed ID: 18067207
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.